Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
出版年份 2019 全文链接
标题
Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-21
DOI
10.1038/s41598-019-48548-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy
- (2018) Samara Camaçari de Carvalho et al. CYTOKINE
- Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy
- (2018) Pietro Spitali et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
- (2018) Craig M McDonald et al. LANCET
- Expression profiling of disease progression in canine model of Duchenne muscular dystrophy
- (2018) Candice Brinkmeyer-Langford et al. PLoS One
- Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies
- (2018) Pietro Spitali et al. Journal of Cachexia Sarcopenia and Muscle
- Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
- (2018) Laurie S. Conklin et al. PHARMACOLOGICAL RESEARCH
- Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy
- (2017) Sandra Murphy et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- lmerTest Package: Tests in Linear Mixed Effects Models
- (2017) Alexandra Kuznetsova et al. Journal of Statistical Software
- Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents
- (2017) Alan S. Robertson et al. NEUROMUSCULAR DISORDERS
- Molekulare Pathogenese der Fibrose bei Muskeldystrophie vom Typ Duchenne
- (2017) K. Ohlendieck et al. PATHOLOGE
- Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy
- (2017) Anna M.L. Coenen-Stass et al. TRENDS IN MOLECULAR MEDICINE
- Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients
- (2016) Stijn Oonk et al. Proteomics Clinical Applications
- Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
- (2016) Simina M. Boca et al. PLoS One
- Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children
- (2016) Yetrib Hathout et al. Scientific Reports
- Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies
- (2015) Jérémy Rouillon et al. HUMAN MOLECULAR GENETICS
- Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
- (2015) Mónica Anaya-Segura et al. MOLECULES
- Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
- (2015) Yetrib Hathout et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
- (2015) Anna M. L. Coenen-Stass et al. Scientific Reports
- Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
- (2015) William Duddy et al. Skeletal Muscle
- Involvement of adiponectin in the pathogenesis of dystrophinopathy
- (2015) Michel Abou-Samra et al. Skeletal Muscle
- Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
- (2014) B. Ayoglu et al. EMBO Molecular Medicine
- Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
- (2014) Yetrib Hathout et al. HUMAN MOLECULAR GENETICS
- Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy
- (2014) Jeremy Rouillon et al. NEUROMUSCULAR DISORDERS
- Beyond antibodies: New affinity reagents to unlock the proteome
- (2014) Bridget Lollo et al. PROTEOMICS
- Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
- (2014) Xihua Li et al. Molecular Therapy-Nucleic Acids
- The physiological response of protease inhibition in dystrophic muscle
- (2013) K. Hollinger et al. Acta Physiologica
- The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
- (2013) Craig M. McDonald et al. MUSCLE & NERVE
- Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy
- (2012) Martin K. Childers et al. Frontiers in Pharmacology
- miRNAs as serum biomarkers for Duchenne muscular dystrophy
- (2011) Davide Cacchiarelli et al. EMBO Molecular Medicine
- Quantitative Proteomic Analysis of Dystrophic Dog Muscle
- (2011) Laetitia Guevel et al. JOURNAL OF PROTEOME RESEARCH
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- Cdo Interacts with APPL1 and Activates AKT in Myoblast Differentiation
- (2010) Gyu-Un Bae et al. MOLECULAR BIOLOGY OF THE CELL
- Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis
- (2009) Hatice Bilgic et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search